Internal Medicine, Endocrinology, Diabetes, & Metabolism · Wilmington, NC
NPI
1427080720
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2421 Silver Stream Ln
Wilmington, NC, 28401
Phone (910) 341-3300
Groups this clinician bills Medicare through
Medicare paid, 2024
$179K
8,875 services
Medicare patients, 2024
358
Average age 74
Drug cost, 2024
$2.9M
7,067 prescriptions
Company payments, 2025
$2,768
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Seth N Braunstein was code J0897 (injection, denosumab, 1 mg), 1,860 times for 18 patients. In total Seth N Braunstein billed 8,875 services in 63 codes, and Medicare paid $179K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,860 | 18 | $20.57 | $38K |
| 99214 Office E&M - Established | Office | 727 | 317 | $84.76 | $62K |
| 36415 Venipuncture Blood Collection | Office | 661 | 290 | $8.65 | $5,718 |
| 80053 Clinical Chemistry | Office | 626 | 286 | $10.35 | $6,479 |
| 84443 Clinical Chemistry | Office | 589 | 272 | $16.46 | $9,695 |
| 80061 Clinical Chemistry | Office | 579 | 260 | $13.09 | $7,578 |
| 83036 Blood Count | Office | 565 | 252 | $9.52 | $5,379 |
| 85025 Blood Count | Office | 561 | 258 | $7.61 | $4,269 |
| 82043 Clinical Chemistry | Office | 481 | 227 | $5.64 | $2,710 |
| 82570 Clinical Chemistry | Office | 481 | 227 | $5.06 | $2,433 |
| 81003 Clinical Chemistry | Office | 433 | 215 | $2.19 | $946 |
| 95251 Test - Miscellaneous | Office | 271 | 112 | $24.98 | $6,769 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 190 | 164 | $11.54 | $2,192 |
| 99215 Office E&M - Established | Office | 91 | 78 | $104.41 | $9,501 |
| 84439 Clinical Chemistry | Office | 58 | 36 | $8.84 | $513 |
By year: 2022 $217K for 12,108 services; 2023 $207K for 10,163 services; 2024 $179K for 8,875 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 661 | 290 | $8.65 | $5,718 |
| 80053 Clinical Chemistry | 626 | 286 | $10.35 | $6,479 |
| 84443 Clinical Chemistry | 589 | 272 | $16.46 | $9,695 |
| 80061 Clinical Chemistry | 579 | 260 | $13.09 | $7,578 |
| 83036 Blood Count | 565 | 252 | $9.52 | $5,379 |
| 85025 Blood Count | 561 | 258 | $7.61 | $4,269 |
| 82570 Clinical Chemistry | 481 | 227 | $5.06 | $2,433 |
| 82043 Clinical Chemistry | 481 | 227 | $5.64 | $2,710 |
| 81003 Clinical Chemistry | 433 | 215 | $2.19 | $946 |
| 84439 Clinical Chemistry | 58 | 36 | $8.84 | $513 |
Medicare prescription drug claims, 2024
In 2024, the drug Seth N Braunstein prescribed most often to Medicare patients was Ozempic (Semaglutide), with 405 prescriptions and refills. In total Seth N Braunstein wrote 7,067 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 405 | 543 | 69 | $500K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 372 | 771 | 98 | $61K |
| Jardiance Empagliflozin | 369 | 763 | 83 | $422K |
| Mounjaro Tirzepatide | 360 | 418 | 62 | $422K |
| Metformin Hcl Er Metformin Hcl | 323 | 937 | 99 | $3,637 |
| Levothyroxine Sodium Generic | 319 | 823 | 93 | $3,834 |
| Novolog Flexpen Insulin Aspart | 209 | 470 | 67 | $56K |
| Metformin Hcl Generic | 191 | 515 | 55 | $1,860 |
| Glimepiride Generic | 174 | 518 | 47 | $1,586 |
| Losartan Potassium Generic | 173 | 469 | 45 | $1,676 |
| Atorvastatin Calcium Generic | 169 | 485 | 55 | $1,573 |
| Humalog Kwikpen U-100 Insulin Lispro | 143 | 293 | 49 | $35K |
| Pioglitazone Hcl Generic | 122 | 348 | 37 | $2,155 |
| Tresiba Flextouch U-100 Insulin Degludec | 105 | 267 | 32 | $78K |
| Lisinopril Generic | 102 | 251 | 26 | $631 |
Brand drugs: 3,590 claims; generic drugs: 2,944 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Seth N Braunstein $2,768 ($2,768 in general payments such as food, travel and fees) from 34 companies. The largest payer was Novo Nordisk Inc with $372.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.